论文部分内容阅读
对口咽癌97例患者体内注射5-溴脱氧核苷(BUDR)200mg作标记肿瘤细胞,4～6小时后瘤体活检进行瘤细胞动态测定研究,试比较化疗组(CT)19例和未化疗组(NT)78例对细胞增殖的影响。97例中,男85例,女12例。年龄平均64.1岁。肿瘤原发扁桃体/软腭53例,舌根23例,咽后壁10例,其余口咽部11例。19例化疗结束后3～7周活检,平均4.1周。化疗后平均随访17.1月,中位数13.1月,据此短期随访临床效果与瘤细胞动态参数间无
Ninety-seven patients with oropharyngeal carcinoma were injected with 200 mg of 5-bromodeoxynucleoside (BUDR) into the tumor cells. The tumor biopsy was performed 4 to 6 hours later. Tumor cells were assayed in 19 patients with chemotherapy and without chemotherapy Effect of Group 78 on Cell Proliferation. 97 cases, 85 males and 12 females. The average age of 64.1 years old. Tumor primary tonsils / soft palate in 53 cases, 23 cases of tongue base, posterior pharyngeal wall in 10 cases, and the remaining 11 oropharynx. 19 cases of biopsy 3 to 7 weeks after the end of chemotherapy, an average of 4.1 weeks. After chemotherapy, the average follow-up of 17.1 months, the median 13.1 months, based on the short-term follow-up of clinical efficacy and tumor cell dynamic parameters between